Distressed-type_Flat_white

If this is your patient’s life, that’s not a life being lived to the fullest

So if you could offer them possible long-term relief from their back and leg pain, why wouldn’t you?

  • Non-drug treatment option
  • Centrally funded by NHS England
  • Trial available

Patient stories: Spinal cord stimulation

Watch stories from people who are using spinal cord stimulation (SCS) to manage chronic pain.

Is there light at the end

of the tunnel from a life

of constant pain?

If your patient is suffering from persistent spinal pain syndrome type 2 – formerly known as failed back surgery syndrome (FBSS) – for 6 months or more, treating them with spinal cord stimulation (SCS) using HFX™SCS technology could offer them the relief they need to get their life back on track.1

Compared to other surgical interventions, spinal cord stimulation can be minimally invasive, patients can test the technology to make sure it suits them, and it is fully reversible.

In fact, HFX™ SCS has been specifically recommended by NICE for the treatment of residual chronic, neuropathic back and leg pain persisting after back surgery since 2019.2

83 %
Patient-Reported Real- World Quality of Life Improvement7

HFX™ is the only technology that uses high-frequency (10 kHz) paraesthesia-free spinal cord stimulation.

  • >70% sustained from 3 months through 10 years

  • HFX™ SCS works directly on the cause of chronic pain

  • NICE recommends adoption of 10 kHz Therapy™ in the NHS

Is HFX™ Spinal Cord Stimulation the answer for your patient?

HFX™ SCS is a form of spinal cord stimulation that uses high-frequency 10 kHz SCS and involves no medication. The device is implanted into the back and sends low-level electrical signals directly into the spinal cord.

Whilst traditional low-frequency spinal cord stimulation simply masks the pain with paraesthesia, high-frequency stimulation with HFX™ actually calms down hyperactive wide dynamic range neurons – working directly on the cause of chronic pain.

HFX™ SCS has proven effectiveness and durability, with a treatment response rate of over 70% sustained from 3 months through to 10 years post-implantation,3,4 and could lead to cost savings for the NHS over time, compared to traditional SCS.

HFX™ SCS has additional advantages related to shorter and more predictable procedure times (increase OR time efficiency) and consequent health-related quality of life benefits for patients.8

Play Video

HFX™ SCS: more than

just pain relief

The effectiveness of HFX™ SCS extends beyond pain relief. Improvements in quality of life (QoL) and satisfaction, as well as a reduction in opioid usage, have all been reported.5–7

The case for adopting Senza spinal cord stimulation (SCS) for delivering 10 kHz therapy as a treatment option for chronic neuropathic back or leg pain after failed back surgery is supported by the evidence.

69 .6 %
of patients receiving 10 kHz TherapyTM moved to a lower disability category.5*
83 %
patient-reported real-world quality of life improvement.7
41 %
fewer opioids were used at 12 months in the SENZA-RCT and SENZA-EU studies using 10 kHz SCS.6

HFX SCS; making
a real difference

HFX™ is supported by evidence from randomised, controlled trials and real-world observational studies and has shown consistent superiority to standard low-frequency SCS.

Non-drug treatment option. HFX™offers consistent pain relief without being addictive, or causing drowsiness or constipation as pain medications can.8
Centrally funded by NHS England. HFX™ treatment is available to both NHS and private patients.
Trial available. A trial device can be used to assess patient acceptability – patients can trial HFX™ and decide whether it is right for them.

Relieving the constant pain of chronic back and leg pain using unique 10 kHz HFX™ SCS therapy could significantly improve your patient’s quality of life.

Find out how your

patient can take the

first step towards

effective pain relief

Refer your patient for a minimally-invasive HFX™ trial procedure at an SCS centre today.